elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34005866-9084C9CE-E1E1-416F-82CF-B8318CE52E08
Q34005866-9084C9CE-E1E1-416F-82CF-B8318CE52E08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34005866-9084C9CE-E1E1-416F-82CF-B8318CE52E08
5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer
P2860
Q34005866-9084C9CE-E1E1-416F-82CF-B8318CE52E08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34005866-9084C9CE-E1E1-416F-82CF-B8318CE52E08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8cb49987c4e322f7bf653429604f33efde36a66
P2860
Long-term survival of participants in the prostate cancer prevention trial.